Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-012229-13Phase 4Active
Phase 4, randomised, open-label trial of ropivacaine and sufentanil in postoperative pain (2 arms), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Dynamic pain during mobilization at 24 hours. Started May 2009; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-012229-13.